Banque Transatlantique’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,250
Closed -$3.99K 274
2025
Q1
$3.99K Buy
+2,250
New +$3.99K ﹤0.01% 767